Several approaches have been proposed to inhibit AQP4 mislocalisation as a treatment for central nervous system (CNS) injury and stroke, with the aim of stabilising the BBB and disrupting the blood-spinal cord barrier disruption167,168. The gene discussed is AQP4; the disease is Stroke.